Global Opioid Use Disorder Market 2019 by Company, Regions, Type and Application, Forecast to 2024
October 2019
105
About the Report
About the Report
Scope of the Report:
The global Opioid Use Disorder market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Opioid Use Disorder.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Opioid Use Disorder market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Opioid Use Disorder market by product type and applications/end industries.
Market Segment by Companies, this report covers
Orexo
Camurus
Hikma Pharmaceuticals
Alkermes
Indivior
Titan Pharmaceuticals
MediciNova
Teva Pharmaceuticals
Omeros
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Buprenorphine
Methadone
Naltrexone
Market Segment by Applications, can be divided into
Moderate Pain Treatment
Severe Pain Treatment
Products
Companies
Orexo
Camurus
Hikma Pharmaceuticals
Alkermes
Indivior
Titan Pharmaceuticals
MediciNova
Teva Pharmaceuticals
Omeros
Table of Contents
Table of Contents
Table of Contents
1 Opioid Use Disorder Market Overview
1.1 Product Overview and Scope of Opioid Use Disorder
1.2 Classification of Opioid Use Disorder by Types
1.2.1 Global Opioid Use Disorder Revenue Comparison by Types (2019-2024)
1.2.2 Global Opioid Use Disorder Revenue Market Share by Types in 2018
1.2.3 Buprenorphine
1.2.4 Methadone
1.2.5 Naltrexone
1.3 Global Opioid Use Disorder Market by Application
1.3.1 Global Opioid Use Disorder Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Moderate Pain Treatment
1.3.3 Severe Pain Treatment
1.4 Global Opioid Use Disorder Market by Regions
1.4.1 Global Opioid Use Disorder Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Opioid Use Disorder Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Opioid Use Disorder Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Opioid Use Disorder Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Opioid Use Disorder Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Opioid Use Disorder Status and Prospect (2014-2024)
1.5 Global Market Size of Opioid Use Disorder (2014-2024)
2 Company Profiles
2.1 Orexo
2.1.1 Business Overview
2.1.2 Opioid Use Disorder Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Orexo Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.2 Camurus
2.2.1 Business Overview
2.2.2 Opioid Use Disorder Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Camurus Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.3 Hikma Pharmaceuticals
2.3.1 Business Overview
2.3.2 Opioid Use Disorder Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Hikma Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.4 Alkermes
2.4.1 Business Overview
2.4.2 Opioid Use Disorder Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Alkermes Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.5 Indivior
2.5.1 Business Overview
2.5.2 Opioid Use Disorder Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Indivior Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.6 Titan Pharmaceuticals
2.6.1 Business Overview
2.6.2 Opioid Use Disorder Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Titan Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.7 MediciNova
2.7.1 Business Overview
2.7.2 Opioid Use Disorder Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 MediciNova Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.8 Teva Pharmaceuticals
2.8.1 Business Overview
2.8.2 Opioid Use Disorder Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
2.9 Omeros
2.9.1 Business Overview
2.9.2 Opioid Use Disorder Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Omeros Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
3 Global Opioid Use Disorder Market Competition, by Players
3.1 Global Opioid Use Disorder Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Opioid Use Disorder Players Market Share
3.2.2 Top 10 Opioid Use Disorder Players Market Share
3.3 Market Competition Trend
4 Global Opioid Use Disorder Market Size by Regions
4.1 Global Opioid Use Disorder Revenue and Market Share by Regions
4.2 North America Opioid Use Disorder Revenue and Growth Rate (2014-2019)
4.3 Europe Opioid Use Disorder Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Opioid Use Disorder Revenue and Growth Rate (2014-2019)
4.5 South America Opioid Use Disorder Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Opioid Use Disorder Revenue and Growth Rate (2014-2019)
5 North America Opioid Use Disorder Revenue by Countries
5.1 North America Opioid Use Disorder Revenue by Countries (2014-2019)
5.2 USA Opioid Use Disorder Revenue and Growth Rate (2014-2019)
5.3 Canada Opioid Use Disorder Revenue and Growth Rate (2014-2019)
5.4 Mexico Opioid Use Disorder Revenue and Growth Rate (2014-2019)
6 Europe Opioid Use Disorder Revenue by Countries
6.1 Europe Opioid Use Disorder Revenue by Countries (2014-2019)
6.2 Germany Opioid Use Disorder Revenue and Growth Rate (2014-2019)
6.3 UK Opioid Use Disorder Revenue and Growth Rate (2014-2019)
6.4 France Opioid Use Disorder Revenue and Growth Rate (2014-2019)
6.5 Russia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
6.6 Italy Opioid Use Disorder Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Opioid Use Disorder Revenue by Countries
7.1 Asia-Pacific Opioid Use Disorder Revenue by Countries (2014-2019)
7.2 China Opioid Use Disorder Revenue and Growth Rate (2014-2019)
7.3 Japan Opioid Use Disorder Revenue and Growth Rate (2014-2019)
7.4 Korea Opioid Use Disorder Revenue and Growth Rate (2014-2019)
7.5 India Opioid Use Disorder Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
8 South America Opioid Use Disorder Revenue by Countries
8.1 South America Opioid Use Disorder Revenue by Countries (2014-2019)
8.2 Brazil Opioid Use Disorder Revenue and Growth Rate (2014-2019)
8.3 Argentina Opioid Use Disorder Revenue and Growth Rate (2014-2019)
8.4 Colombia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Opioid Use Disorder by Countries
9.1 Middle East and Africa Opioid Use Disorder Revenue by Countries (2014-2019)
9.2 Saudi Arabia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
9.3 UAE Opioid Use Disorder Revenue and Growth Rate (2014-2019)
9.4 Egypt Opioid Use Disorder Revenue and Growth Rate (2014-2019)
9.5 Nigeria Opioid Use Disorder Revenue and Growth Rate (2014-2019)
9.6 South Africa Opioid Use Disorder Revenue and Growth Rate (2014-2019)
10 Global Opioid Use Disorder Market Segment by Type
10.1 Global Opioid Use Disorder Revenue and Market Share by Type (2014-2019)
10.2 Global Opioid Use Disorder Market Forecast by Type (2019-2024)
10.3 Buprenorphine Revenue Growth Rate (2014-2024)
10.4 Methadone Revenue Growth Rate (2014-2024)
10.5 Naltrexone Revenue Growth Rate (2014-2024)
11 Global Opioid Use Disorder Market Segment by Application
11.1 Global Opioid Use Disorder Revenue Market Share by Application (2014-2019)
11.2 Opioid Use Disorder Market Forecast by Application (2019-2024)
11.3 Moderate Pain Treatment Revenue Growth (2014-2019)
11.4 Severe Pain Treatment Revenue Growth (2014-2019)
12 Global Opioid Use Disorder Market Size Forecast (2019-2024)
12.1 Global Opioid Use Disorder Market Size Forecast (2019-2024)
12.2 Global Opioid Use Disorder Market Forecast by Regions (2019-2024)
12.3 North America Opioid Use Disorder Revenue Market Forecast (2019-2024)
12.4 Europe Opioid Use Disorder Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Opioid Use Disorder Revenue Market Forecast (2019-2024)
12.6 South America Opioid Use Disorder Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Opioid Use Disorder Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Figure
List of Tables and Figures
Figure Opioid Use Disorder Picture
Table Product Specifications of Opioid Use Disorder
Table Global Opioid Use Disorder and Revenue (Million USD) Market Split by Product Type
Figure Global Opioid Use Disorder Revenue Market Share by Types in 2018
Figure Buprenorphine Picture
Figure Methadone Picture
Figure Naltrexone Picture
Table Global Opioid Use Disorder Revenue (Million USD) by Application (2014-2024)
Figure Opioid Use Disorder Revenue Market Share by Applications in 2018
Figure Moderate Pain Treatment Picture
Figure Severe Pain Treatment Picture
Table Global Market Opioid Use Disorder Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Opioid Use Disorder Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Opioid Use Disorder Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Opioid Use Disorder Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Opioid Use Disorder Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Opioid Use Disorder Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Opioid Use Disorder Revenue (Million USD) and Growth Rate (2014-2024)
Table Orexo Basic Information, Manufacturing Base and Competitors
Table Orexo Opioid Use Disorder Type and Applications
Table Orexo Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Camurus Basic Information, Manufacturing Base and Competitors
Table Camurus Opioid Use Disorder Type and Applications
Table Camurus Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Hikma Pharmaceuticals Opioid Use Disorder Type and Applications
Table Hikma Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Alkermes Basic Information, Manufacturing Base and Competitors
Table Alkermes Opioid Use Disorder Type and Applications
Table Alkermes Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Indivior Basic Information, Manufacturing Base and Competitors
Table Indivior Opioid Use Disorder Type and Applications
Table Indivior Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Titan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Titan Pharmaceuticals Opioid Use Disorder Type and Applications
Table Titan Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table MediciNova Basic Information, Manufacturing Base and Competitors
Table MediciNova Opioid Use Disorder Type and Applications
Table MediciNova Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceuticals Opioid Use Disorder Type and Applications
Table Teva Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Omeros Basic Information, Manufacturing Base and Competitors
Table Omeros Opioid Use Disorder Type and Applications
Table Omeros Opioid Use Disorder Revenue, Gross Margin and Market Share (2017-2018)
Table Global Opioid Use Disorder Revenue (Million USD) by Players (2014-2019)
Table Global Opioid Use Disorder Revenue Share by Players (2014-2019)
Figure Global Opioid Use Disorder Revenue Share by Players in 2017
Figure Global Opioid Use Disorder Revenue Share by Players in 2018
Figure Global Top 5 Players Opioid Use Disorder Revenue Market Share in 2018
Figure Global Top 10 Players Opioid Use Disorder Revenue Market Share in 2018
Figure Global Opioid Use Disorder Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Opioid Use Disorder Revenue (Million USD) by Regions (2014-2019)
Table Global Opioid Use Disorder Revenue Market Share by Regions (2014-2019)
Figure Global Opioid Use Disorder Revenue Market Share by Regions (2014-2019)
Figure Global Opioid Use Disorder Revenue Market Share by Regions in 2018
Figure North America Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Europe Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure South America Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Table North America Opioid Use Disorder Revenue by Countries (2014-2019)
Table North America Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure North America Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure North America Opioid Use Disorder Revenue Market Share by Countries in 2018
Figure USA Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Canada Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Mexico Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Table Europe Opioid Use Disorder Revenue (Million USD) by Countries (2014-2019)
Figure Europe Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure Europe Opioid Use Disorder Revenue Market Share by Countries in 2018
Figure Germany Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure UK Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure France Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Russia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Italy Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Opioid Use Disorder Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Opioid Use Disorder Revenue Market Share by Countries in 2018
Figure China Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Japan Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Korea Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure India Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Table South America Opioid Use Disorder Revenue by Countries (2014-2019)
Table South America Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure South America Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure South America Opioid Use Disorder Revenue Market Share by Countries in 2018
Figure Brazil Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Argentina Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Colombia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Opioid Use Disorder Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Opioid Use Disorder Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Opioid Use Disorder Revenue Market Share by Countries in 2018
Figure Saudi Arabia Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure UAE Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Egypt Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure Nigeria Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Figure South Africa Opioid Use Disorder Revenue and Growth Rate (2014-2019)
Table Global Opioid Use Disorder Revenue (Million USD) by Type (2014-2019)
Table Global Opioid Use Disorder Revenue Share by Type (2014-2019)
Figure Global Opioid Use Disorder Revenue Share by Type (2014-2019)
Figure Global Opioid Use Disorder Revenue Share by Type in 2018
Table Global Opioid Use Disorder Revenue Forecast by Type (2019-2024)
Figure Global Opioid Use Disorder Market Share Forecast by Type (2019-2024)
Figure Global Buprenorphine Revenue Growth Rate (2014-2019)
Figure Global Methadone Revenue Growth Rate (2014-2019)
Figure Global Naltrexone Revenue Growth Rate (2014-2019)
Table Global Opioid Use Disorder Revenue by Application (2014-2019)
Table Global Opioid Use Disorder Revenue Share by Application (2014-2019)
Figure Global Opioid Use Disorder Revenue Share by Application (2014-2019)
Figure Global Opioid Use Disorder Revenue Share by Application in 2018
Table Global Opioid Use Disorder Revenue Forecast by Application (2019-2024)
Figure Global Opioid Use Disorder Market Share Forecast by Application (2019-2024)
Figure Global Moderate Pain Treatment Revenue Growth Rate (2014-2019)
Figure Global Severe Pain Treatment Revenue Growth Rate (2014-2019)
Figure Global Opioid Use Disorder Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Opioid Use Disorder Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Opioid Use Disorder Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Opioid Use Disorder Revenue Market Forecast (2019-2024)
Figure Europe Opioid Use Disorder Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Opioid Use Disorder Revenue Market Forecast (2019-2024)
Figure South America Opioid Use Disorder Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Opioid Use Disorder Revenue Market Forecast (2019-2024)
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.